Amenorrhea after chemoembolization and suction curettage of caesarean scar pregnancy.

Ginekol Pol

3rd Department of Gynecology, ul.Jaczewskiego 8, 20-954 Lublin, Poland.

Published: July 2018

Download full-text PDF

Source
http://dx.doi.org/10.5603/GP.a2017.0114DOI Listing

Publication Analysis

Top Keywords

amenorrhea chemoembolization
4
chemoembolization suction
4
suction curettage
4
curettage caesarean
4
caesarean scar
4
scar pregnancy
4
amenorrhea
1
suction
1
curettage
1
caesarean
1

Similar Publications

Introduction: Caesarean scar pregnancy (CSP) is a relatively rare yet life-threatening condition in which the embryo is implanted in the scar after caesarean section. Recent studies have reported that uterine artery chemoembolisation (UAC) can be safe and effective method in treating CSP.

Aim: To present the clinical outcome of UAC with a mixture of methotrexate and gelatine sponge for the treatment of CSP and analysis of procedural failure.

View Article and Find Full Text PDF

Objective: Caesarean scar pregnancy (CSP) is a rare form of ectopic pregnancy implanted in a previous caesarean scar. Selective chemoembolization with methotrexate (SCEM) followed by suction curettage (SC) is one of the treatment options for CSP. The aim of the study was to assess the effectiveness, complications and reproductive outcome of SCEM followed by SC in the treatment of CSP.

View Article and Find Full Text PDF

Caesarean Scar Ectopic Pregnancy: Report of Two Cases.

J Clin Diagn Res

May 2016

Medical Director, Institute of Reproductive Medicine, Madras Medical Mission , Chennai, Tamilnadu, India .

Cases of Caesarean Scar Ectopic Pregnancy (CSEP) are becoming increasingly common at tertiary care hospitals because of increase in rate of CS. This condition is often complicated by life threatening bleeding, uterine rupture, which might require hysterectomy leading to permanent infertility. Management can be medical, surgical or combined depending on the clinical presentation.

View Article and Find Full Text PDF

Amenorrhea as a rare drug-related adverse event associated with everolimus for pancreatic neuroendocrine tumors.

World J Gastroenterol

November 2014

Yoshiaki Kawaguchi, Atsuko Maruno, Yohei Kawashima, Hiroyuki Ito, Masami Ogawa, Tetsuya Mine, Department of Gastroenterology, Tokai University School of Medicine, Isehara 259-1193, Japan.

The patient was an asymptomatic 43-year-old woman. Abdominal ultrasonography and enhanced computed tomography showed a tumor lesion accompanied by multiple cystic changes in the liver and the pancreatic tail. Endoscopic ultrasound-fine needle aspiration was performed on the pancreatic tumor lesion and revealed pancreatic neuroendocrine tumor (PNET).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!